A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder
By: Handen, Benjamin L.
Contributor(s): Melmed, Raun D | Hansen, Robin L | et al.
Series: Journal of Autism and Developmental Disorders 39 (5) 2009: 796-805.Publisher: 2009Content type: text Media type: unmediated Carrier type: volume Subject(s): CHILDREN
| AUTISM | GASTROINTESTINAL DISORDERS | IMMUNOGLOBULIN | RESEARCHSummary: Observes that controversy exists regarding the extent and possible causal relationship between gastrointestinal symptoms and autism. Describes a study using oral immunoglobulin with 125 children (ages 2 to 17) with autism and persistent GI symptoms. No beneficial effect of IGOH was detected compared with placebo.
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
| Article Research | IHC Library | Article (Browse shelf(Opens below)) | Available (Article available on request) | 25506 |
Total holds: 0
Observes that controversy exists regarding the extent and possible causal relationship between gastrointestinal symptoms and autism. Describes a study using oral immunoglobulin with 125 children (ages 2 to 17) with autism and persistent GI symptoms. No beneficial effect of IGOH was detected compared with placebo.
There are no comments on this title.
Log in to your account to post a comment.
